|
Q3 2022
Filed on Nov 14, 2022
|
1,713,128
|
$0.47 - $9.8
$805K - $16.8M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
85,529,412
|
$4.93 - $24.72
$422M - $2.11B
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
4,004,291
|
$0.0 - $1.05
$0 - $4.2M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
3,009,161
|
$0.0 - $95.99
$0 - $289M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
26,830
|
$171.79 - $199.02
$4.61M - $5.34M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,258,447
|
$0.14 - $135.6
$176K - $171M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
5,241,282
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
283,328
|
$4.88 - $9.95
$1.38M - $2.82M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
502,622
|
$0.0 - $2.2
$0 - $1.11M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
25,387,333
|
$0.1 - $0.75
$2.54M - $19M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
9,223,322
|
$0.0 - $65.24
$0 - $602M
|
|
Sonnet Biotherapeutc Hldng I
|
Q3 2022
Filed on Nov 14, 2022
|
1,887,987
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,240,416
|
$0.28 - $3.2
$627K - $7.17M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
43,959
|
$0.06 - $2.44
$2.64K - $107K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
128,788
|
$0.0 - $0.48
$0 - $61.8K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
841,558
|
$0.2 - $424.56
$168K - $357M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,317,485
|
$0.0 - $10.52
$0 - $24.4M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,603,467
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
5,296,501
|
$0.99 - $2.4
$5.24M - $12.7M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
288,640
|
$15.13 - $15.13
$4.37M - $4.37M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
310,331
|
$10.07 - $17.26
$3.13M - $5.36M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
54,649
|
$0.23 - $0.45
$12.6K - $24.6K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
131,569
|
$0.24 - $756.0
$31.6K - $99.5M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,101,720
|
$0.0 - $216.46
$0 - $455M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
683,896
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
4,758,768
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
72,664
|
$2.14 - $16.63
$156K - $1.21M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
897,358
|
$0.0 - $4.48
$0 - $4.02M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
143,821,556
|
$6.04 - $26.64
$869M - $3.83B
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
9,946,969
|
$0.17 - $4.5
$1.69M - $44.8M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,035,806
|
$0.16 - $2.48
$326K - $5.05M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
5,178,466
|
$1.01 - $24.84
$5.23M - $129M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,882,608
|
$0.78 - $8.9
$2.25M - $25.7M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
20,080,308
|
$0.0 - $65.42
$0 - $1.31B
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,682,145
|
$0.02 - $0.23
$53.6K - $617K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
4,666,439
|
$0.0 - $39.9
$0 - $186M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
570,124
|
$0.0 - $6.33
$0 - $3.61M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
67,212
|
$0.12 - $64.44
$8.07K - $4.33M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
11,250,736
|
$0.0 - $54.84
$0 - $617M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,791,796
|
$0.0 - $173.69
$0 - $485M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
4,600,470
|
$0.0 - $1.5
$0 - $6.9M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
20,895,870
|
$0.0 - $22.98
$0 - $480M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
19,012
|
$0.0 - $8.74
$0 - $166K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
9,559,564
|
$0.27 - $8.33
$2.58M - $79.6M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,304,514
|
$0.17 - $1.35
$222K - $1.76M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,561,409
|
$0.01 - $0.08
$15.6K - $125K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
10,724
|
$10.73 - $13.7
$115K - $147K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,039,148
|
$0.02 - $0.22
$20.8K - $229K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
3,104,024
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,536,391
|
$0.0 - $11.32
$0 - $28.7M
|
|